Aducanumab for Alzheimer ' s Gets Thumbs Down in Europe Aducanumab for Alzheimer ' s Gets Thumbs Down in Europe

An EMA advisory panel has recommended against approving aducanumab for Alzheimer ' s saying that, overall, study results did not show the drug was effective for early disease.News Alerts
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Psychiatry News Alert Source Type: news